Bita Mesgarpour

Zitiert von

	Alle	Seit 2019
Zitate	1754	872
h-index	23	17
i10-index	36	25

200

100

150

200520062007200820092010201120122013201420152016201720182019202020212022202320246 19 27 39 43 39 64 60 82 81 86 74 128 116 122 138 155 192 200 56

Öffentlicher Zugriff

Alle anzeigen

3 Artikel

0 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

MohammadReza MohammadiPsychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical SciencesBestätigte E-Mail-Adresse bei tums.ac.ir
Shahin AkhondzadehPsychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, IranBestätigte E-Mail-Adresse bei neda.net
Mehdi RahgozarAssociate Professor of Biostatistics, University of Social Welfare and Rehabilitation SciencesBestätigte E-Mail-Adresse bei uswr.ac.ir
Homayoun AminiProfessor of Psychiatry, Roozbeh Hospital, Tehran University of Medical SciencesBestätigte E-Mail-Adresse bei tums.ac.ir
Ahmad Ali NoorbalaPsychosomatic Medicine Research Center, Imam Khomeini Hospital, Tehran University of Medical SciencesBestätigte E-Mail-Adresse bei tums.ac.ir
AliAkbar HaghdoostKerman University of Medical SciencesBestätigte E-Mail-Adresse bei kmu.ac.ir
Payam KabiriTehran University of Medical SciencesBestätigte E-Mail-Adresse bei tums.ac.ir
Anahita Basirnia/Bassirnia/Bassir Nia/...Assistant Professor of Psychiatry, Yale University School of MedicineBestätigte E-Mail-Adresse bei yale.edu
Ali FarhoudianTehran University of Medical SciencesBestätigte E-Mail-Adresse bei sina.tums.ac.ir
Reza Malekzadeh M.DProfessor of Internal Medicine ,&Gastroenterology Tehran University of Medical Sciences, IranBestätigte E-Mail-Adresse bei tums.ac.ir
Benedikt Heidinger, MD, PhDBeth Israel Deaconess Medical CenterBestätigte E-Mail-Adresse bei bidmc.harvard.edu
Mohammad Javad Nasiri, PhD, MPHShahid Beheshti Medical University in Iran. Email: mj.nasiri@hotmail.comBestätigte E-Mail-Adresse bei sbmu.ac.ir
naghmeh mansouriSchool of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Mental HealthBestätigte E-Mail-Adresse bei kar.iums.ac.ir
Reza Yousefi NooraieAssistant Professor, Department of Public Health Sciences, University of RochesterBestätigte E-Mail-Adresse bei urmc.rochester.edu
Vandad SharifiAssociate Professor of Psychiatry, Tehran University of Medical SciencesBestätigte E-Mail-Adresse bei tums.ac.ir
Shahin MeratProfessor of Medicine, Tehran University of Medical SciencesBestätigte E-Mail-Adresse bei tums.ac.ir
Seyed Mehdi SaberiPsychiatrist, Associate prof. of Legal Medicine Research Center, Legal Medicine Organization of IranBestätigte E-Mail-Adresse bei lmrc.ir
Cathal WalshProfessor of Biostatistics, Trinity College DublinBestätigte E-Mail-Adresse bei tcd.ie
Markus MüllerMedical University of ViennaBestätigte E-Mail-Adresse bei meduniwien.ac.at
Behzad HajarizadehViral Hepatitis Clinical Research Program, The Kirby Institute, The University of New South WalesBestätigte E-Mail-Adresse bei kirby.unsw.edu.au

Folgen

Bita Mesgarpour

Associate Professor, National Institute for Medical Research Development (NIMAD), Tehran, Iran

Bestätigte E-Mail-Adresse bei research.ac.ir

Pharmacoepidemiology Pharmacovigilance Information retrieval Epidemiology Scientometry


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
An epidemiological survey of psychiatric disorders in Iran MR Mohammadi, H Davidian, AA Noorbala, H Malekafzali, HR Naghavi, ... Clinical practice and epidemiology in mental health 1, 1-8, 2005	407	2005
Prevalence of obsessive-compulsive disorder in Iran MR Mohammadi, A Ghanizadeh, M Rahgozar, A Noorbala, H Davidian, ... BMC psychiatry 4 (1), 2, 2004	165	2004
Acupuncture or acupressure for pain management during labour CA Smith, CT Collins, KM Levett, M Armour, HG Dahlen, AL Tan, ... Cochrane Database of Systematic Reviews, 2020	132	2020
Prevalence of social phobia and its comorbidity with psychiatric disorders in Iran MR Mohammadi, A Ghanizadeh, M Mohammadi, B Mesgarpour Depression and anxiety 23 (7), 405-411, 2006	67	2006
Prevalence of psychiatric disorders in Iran: A systematic review A Farhoudian, V Sharifi, H Amini, A Basirnia, B Mesgarpour, N Mansouri, ... IRANIAN JOURNAL OF PSYCHIATRY 2 (4), 137-150, 2007	55	2007
Prevalence of mood disorders in Iran MR Mohammadi, ZA GHANI, H Davidian, AA NOURBALA, AH MALEK, ... IRANIAN JOURNAL OF PSYCHIATRY 1 (2), 59-64, 2006	53	2006
Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial MR Mohammadi, A Ghanizadeh, J Alaghband-Rad, M Tehranidoost, ... Journal of Child & Adolescent Psychopharmacology 14 (3), 418-425, 2004	51	2004
Harms of off‐label erythropoiesis‐stimulating agents for critically ill people B Mesgarpour, BH Heidinger, D Roth, S Schmitz, CD Walsh, H Herkner Cochrane Database of Systematic Reviews, 2017	40	2017
Extended‐release opioids in the management of cancer pain: A systematic review of efficacy and safety B Mesgarpour, U Griebler, A Glechner, C Kien, M Strobelberger, ... European Journal of Pain 18 (5), 605-616, 2014	40	2014
L‐carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double‐blind study S Arabzadeh, M Shahhossenie, B Mesgarpour, F Rezaei, MR Shalbafan, ... Human Psychopharmacology: clinical and experimental 32 (4), e2584, 2017	38	2017
l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial R Hajizadeh-Zaker, A Ghajar, B Mesgarpour, M Afarideh, ... Journal of child and adolescent psychopharmacology 28 (1), 74-81, 2018	37	2018
Epidemiological Study of Psychiatric Disorders in Tehran Province MR Mohammadi, M Rahgozar, A Bagheri Yazdi, HR Naghavi, ... Iranian Journal of Psychiatry and Clinical Psychology 9 (2(34)), 4-14, 2003	36	2003
Herbal medicine in Iran HR Adhami, B Mesgarpour, H Farsam Herbalgram 74, 34-43, 2007	34	2007
Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis B Mesgarpour, BH Heidinger, M Schwameis, C Kienbacher, C Walsh, ... Intensive care medicine 39, 1896-1908, 2013	30	2013
Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis H Hatami, G Sotgiu, N Bostanghadiri, SSD Abadi, B Mesgarpour, ... Jornal Brasileiro de Pneumologia 48, e20210384, 2022	29	2022
Research assessment of Iranian medical universities, an experience from a developing country E Habibi, B Mesgarpour, M Vasei Iranian J Publ Health 38 (1), 47-9, 2009	29	2009
Health research system resilience: lesson learned from the COVID-19 crisis B Yazdizadeh, R Majdzadeh, A Ahmadi, B Mesgarpour Health Research Policy and Systems 18 (1), 136, 2020	28	2020
Interventions to improve adverse drug reaction reporting: a scoping review M Khalili, B Mesgarpour, H Sharifi, S Daneshvar Dehnavi, AA Haghdoost Pharmacoepidemiology and Drug Safety 29 (9), 965-992, 2020	28	2020
Comparative risk of harm associated with the use of targeted immunomodulators: a systematic review RJ Desai, KJ Thaler, P Mahlknecht, G Gartlehner, MS McDonagh, ... Arthritis Care & Research 68 (8), 1078-1088, 2016	28	2016
Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial E Moazen-Zadeh, S Bayanati, K Ziafat, F Rezaei, B Mesgarpour, ... Journal of Psychopharmacology 34 (5), 506-513, 2020	27	2020

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren